Friday, October 16, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 4, 2026

Avery Dennison outlines 6% Q1 2026 EPS growth target as high-value category mix accelerates

View original at seekingalpha.com
Avery Dennison outlines 6% Q1 2026 EPS growth target as high-value category mix accelerates Earnings Call Insights: Avery Dennison Corporation (AVY) Q4 2025 MANAGEMENT VIEW * Deon Stander, President, CEO & Director, stated the company delivered adjusted EPS of $9.53 and $707 million of adjusted free cash flow for 2025,…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Materials Group saw reported sales increase 5%, with high-value categories now representing 38% of the segment's portfolio, and Intelligent Label delivering high single-digit growth

    80% confidence
  • Walmart rollout would ramp in Q4 2026 and accelerate into 2027

    80% confidence
  • Walmart rollout would ramp in Q4 2026 and accelerate into 2027

    80% confidence
  • The temporary savings headwind is on an order of magnitude basis probably pretty similar to the size of the restructuring actions, that $50 million

    80% confidence
  • Does not anticipate an increase in customer acquisition costs and feels confident in the company's paper supply risk management

    80% confidence
  • The Walmart announcement increased pipeline interest, indicating positive market reception

    80% confidence
  • High-value categories have margins a number of points above the company's average, and significantly above base categories

    80% confidence
  • High-value categories in Solutions Group make up 60% of the portfolio

    80% confidence
  • Higher working capital was due to high-value category mix, and CapEx will support both productivity and future capacity

    80% confidence
  • Vestcom grew over 10% in Q4

    80% confidence
  • Expects compliance enforcement in general retail to provide a tailwind and mentioned expanded logistics pilots with new customers

    80% confidence
  • Growth acceleration will be driven by new customer acquisition, faster innovation cycles, and leveraging digital and AI investments

    80% confidence
  • The company does not anticipate an increase in customer acquisition costs and feels confident in paper supply risk management

    80% confidence
  • I do not anticipate an increase in customer acquisition costs and feel confident in the company's paper supply risk management

    80% confidence
  • High-value categories provided necessary offset to base solutions, which continue to be impacted by tariff-related uncertainty

    80% confidence
  • Does not anticipate an increase in customer acquisition costs

    80% confidence
  • In the fourth quarter, we delivered solid adjusted earnings per share of $2.45, up 3% compared to prior year

    80% confidence
  • Apparel business saw a 7% decline, greater than anticipated, primarily due to changes in retailer ordering behavior amid tariff uncertainty

    80% confidence
  • Does not anticipate an increase in customer acquisition costs and feels confident in the company's paper supply risk management

    80% confidence
  • Base categories were down low single digits in Q4, lower than expected, on softer customer volumes

    80% confidence
  • Restructuring savings of approximately $50 million expected as company continues to execute productivity playbook

    80% confidence
  • The company delivered adjusted EPS of $9.53 and $707 million of adjusted free cash flow for 2025, demonstrating the durability of the franchise and ability to activate multiple levers across a range of macro scenarios

    80% confidence
  • The temporary savings headwind is on an order of magnitude probably similar to the size of the restructuring actions, approximately $50 million

    80% confidence
  • Given key economic indicators remain largely consistent with 2025 levels, the company is not planning for any macroeconomic tailwinds in the near term

    80% confidence
  • Pricing typically follows raw material input cost changes, with productivity actions aimed at offsetting wage inflation

    80% confidence
  • Not happy with the way organic growth trajectory has been over the last couple of years

    80% confidence
  • Expects compliance enforcement in general retail to provide a tailwind and mentioned expanded logistics pilots with new customers

    80% confidence
  • Intelligent Labels delivered high single-digit growth

    80% confidence
  • We expect restructuring savings of approximately $50 million as we continue to execute our productivity playbook, and we expect the normalization of a majority of the 2025 temporary savings

    80% confidence
  • Management is not happy with the organic growth trajectory over the last couple of years

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com